COMMUNIQUÉS West-GlobeNewswire
-
Pelthos Therapeutics Added to Russell 3000E™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes
30/06/2026 -
Kestra Medical Technologies to Report Fourth Quarter Fiscal 2026 Financial Results on July 14
30/06/2026 -
Crinetics Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 4, 2026
30/06/2026 -
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
30/06/2026 -
Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline
30/06/2026 -
AGC Biologics Expands to Fill-Finish in U.S. Through Strategic Partnership with Pyramid Pharma Services
30/06/2026 -
Breckenridge Distillery Earns Double Gold for Rum Cask Finish at New York International Spirits Competition
30/06/2026 -
Cosmos Health Authorizes Up to $5 Million Share Repurchase Program
30/06/2026 -
CBDWatchlist.com Introduces 2026 CBD Gummies and CBD Oil Transparency Review Initiative
30/06/2026 -
Travel Fatigue Treatments Gain Traction as Summer Travel Increases, Says Prana IV Therapy
30/06/2026 -
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds
30/06/2026 -
TPN.health Introduces Proprietary Integrated Claims and Credentialing Platform: Resolves Patient Barriers to Behavioral Health Access and Ensures Clinician Payments
30/06/2026 -
Exicure Announces Board and Committee Changes
30/06/2026 -
SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards
30/06/2026 -
PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited
30/06/2026 -
Celebrate the Fourth—Without Damaging Your Hearing or Losing Your Voice
30/06/2026 -
Serenity Medical Receives U.S. FDA Breakthrough Device Designation for The Serenity Shepherd Stent™ System to Treat Pulsatile Tinnitus
30/06/2026 -
Arizona Nonprofit Launches "Second Chance" Fundraiser for Custom Lexus LX 700h Overtrail to Benefit Childhood Blindness Research
30/06/2026 -
Arcutis Launches New Virtual Health Platform Supporting Access to Care for Individuals Living with Chronic Inflammatory Skin Diseases, Including Approved ZORYVE® (roflumilast) Indications
30/06/2026
Pages